Geode Capital Management
VNRX icon

Geode Capital Management’s VolitionRx Ltd VNRX Stock Holding History

Geode Capital Management’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$249K Buy
61,504
+13,305
+28% +$63.5K ﹤0.01% 3847
2025
Q4 		$246K Buy
48,199
+4,290
+10% +$32.6K ﹤0.01% 3842
2025
Q3 		$596K Buy
43,909
+5,664
+15% +$75.4K ﹤0.01% 3550
2025
Q2 		$581K Buy
38,245
+147
+0.4% +$1.62K ﹤0.01% 3506
2025
Q1 		$434K Buy
38,098
+906
+2% +$10.8K ﹤0.01% 3599
2024
Q4 		$446K Buy
37,192
+670
+2% +$8.99K ﹤0.01% 3635
2024
Q3 		$439K Buy
36,522
+4,795
+15% +$61.7K ﹤0.01% 3635
2024
Q2 		$384K Buy
31,727
+859
+3% +$12.6K ﹤0.01% 3667
2024
Q1 		$467K Buy
30,868
+2,997
+11% +$58.8K ﹤0.01% 3644
2023
Q4 		$400K Buy
27,871
+949
+4% +$13.9K ﹤0.01% 3697
2023
Q3 		$371K Buy
26,922
+3,661
+16% +$90.5K ﹤0.01% 3718
2023
Q2 		$647K Buy
23,261
+8,625
+59% +$284K ﹤0.01% 3535
2023
Q1 		$559K Hold
14,636
– – ﹤0.01% 3598
2022
Q4 		$711K Buy
14,636
+218
+2% +$8.46K ﹤0.01% 3517
2022
Q3 		$392K Hold
14,418
– – ﹤0.01% 3857
2022
Q2 		$591K Buy
14,418
+278
+2% +$14K ﹤0.01% 3676
2022
Q1 		$851K Buy
14,140
+666
+5% +$37.7K ﹤0.01% 3689
2021
Q4 		$846K Sell
13,474
-67
-0.5% -$4.57K ﹤0.01% 3787
2021
Q3 		$839K Buy
13,541
+436
+3% +$27.6K ﹤0.01% 3779
2021
Q2 		$862K Sell
13,105
-11,585
-47% -$784K ﹤0.01% 3686
2021
Q1 		$1.87M Buy
24,690
+4,442
+22% +$381K ﹤0.01% 3281
2020
Q4 		$1.57M Buy
20,248
+2,500
+14% +$172K ﹤0.01% 3204
2020
Q3 		$1.14M Buy
17,748
+97
+0.5% +$6.59K ﹤0.01% 3159
2020
Q2 		$1.37M Buy
17,651
+7,409
+72% +$535K ﹤0.01% 3033
2020
Q1 		$637K Hold
10,242
– – ﹤0.01% 3198
2019
Q4 		$970K Sell
10,242
-621
-6% -$64.4K ﹤0.01% 3288
2019
Q3 		$1.22M Buy
10,863
+4,497
+71% +$358K ﹤0.01% 3161
2019
Q2 		$399K Buy
6,366
+1,321
+26% +$85.6K ﹤0.01% 3550
2019
Q1 		$327K Hold
5,045
– – ﹤0.01% 3585
2018
Q4 		$182K Hold
5,045
– – ﹤0.01% 3705
2018
Q3 		$261K Hold
5,045
– – ﹤0.01% 3685
2018
Q2 		$201K Hold
5,045
– – ﹤0.01% 3719
2018
Q1 		$242K Hold
5,045
– – ﹤0.01% 3628
2017
Q4 		$296K Hold
5,045
– – ﹤0.01% 3542
2017
Q3 		$265K Hold
5,045
– – ﹤0.01% 3576
2017
Q2 		$357K Hold
5,045
– – ﹤0.01% 3486
2017
Q1 		$405K Hold
5,045
– – ﹤0.01% 3383
2016
Q4 		$461K Hold
5,045
– – ﹤0.01% 3293
2016
Q3 		$534K Buy
5,045
+1,862
+58% +$145K ﹤0.01% 3221
2016
Q2 		$200K Hold
3,183
– – ﹤0.01% 3598
2016
Q1 		$226 Buy
+3,183
New +$239K ﹤0.01% 3591

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management's VNRX Position: Q1 2026 in Review

Geode Capital Management increased its VolitionRx Ltd (VNRX) stake by 28% in Q1 2026, buying an estimated $63.5K and bringing the position to 61,504 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #3847.

Geode Capital Management first reported a position in VNRX in Q1 2016 and has held it in 41 quarters since. The position peaked at $1.87M in Q1 2021. 31 funds tracked by Wall St. Rank hold VNRX as of Q1 2026.

  • Geode Capital Management held 61,504 shares of VolitionRx Ltd worth $249K as of Q1 2026.
  • Geode Capital Management bought 13,305 VolitionRx Ltd shares in Q1 2026, an estimated $63.5K.
  • VolitionRx Ltd made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3847 holding.
  • Geode Capital Management first reported a position in VolitionRx Ltd in Q1 2016 and has held it in 41 quarters since.
  • Geode Capital Management's VolitionRx Ltd position peaked at $1.87M in Q1 2021.
  • 31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.